Skip to content

Clinical trials

Phase 2 Hypogonadism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 2 Country / region: United States Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20045
20052
20066
20072
20083
20093
20104
20116
20122
20131
20141
20151
20164
20172
20193
20213
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated6
Recruiting4
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clarus Therapeutics, Inc.5
Massachusetts General Hospital5
Repros Therapeutics Inc.5
Mereo BioPharma3
Stephanie B. Seminara, MD3
Acerus Pharmaceuticals Corporation2
Eli Lilly and Company2
QuatRx Pharmaceuticals Company2
Seattle Institute for Biomedical and Clinical Research2
Solvay Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism54
Eunuchism8
Endocrine System Diseases4
Erectile Dysfunction4
Gonadal Disorders4
Diabetes Mellitus, Type 23
Sexual Dysfunction, Physiological3
Bone Resorption2
Central Nervous System Diseases2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.